ReViral Ltd

ReViral is a UKbased biotechnology company developing firstinclass drugs to treat RSV infections.

Type

B2c

Founded

2011

Raised

$99M

Follow us

Also headquartered in London

Companies in the same industry

Alexa global traffic share

Twitter followers

Built with ❤︎ by Datalicious ©2020
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

Add info

Latest funding

$44,000,000

Venture capital (Series C) - 2020

New Leaf Venture Partners Perceptive Advisors OrbiMed Advisors +5

$55,000,000

Venture capital (Series B) - 2018

New Leaf Venture Partners Perceptive Advisors OrbiMed +3

Team Size

1–10

Employees

Location

Headquarters

$44,000,000 Venture capital (Series C)

$55,000,000 Venture capital (Series B)

, ,